Key Findings
DESU® Mannitol 200SD, a spray-dried mannitol grade, showed favorable powder-flow characteristics in the reported comparison, with an angle of repose of 39° and a Hausner ratio of 1.21.
Crystalline DESU® Mannitol 160C showed an angle of repose of 50° and a Hausner ratio of 1.43, while the mannitol sample without secondary granulation recorded values of 48° and 1.29, respectively.
In the reported blank-tablet compression tests, DESU® Mannitol 200SD demonstrated higher tablet hardness and lower friability across the tested compression pressures. These results highlight the importance of particle structure, powder flowability and tabletability when selecting mannitol for direct compression.
Introduction
Pharmaceutical-grade mannitol is widely used as a filler in oral solid dosage forms. Its powder properties and compaction behavior can influence powder handling, tablet formation and manufacturing performance, particularly in direct compression processes.
Different mannitol grades may vary in particle morphology, particle structure and bulk density. These differences can affect mannitol powder flowability, compressibility and tabletability, making grade selection an important consideration during formulation development.
This article examines how secondary granulation and particle structure relate to mannitol performance, using reported data for spray-dried DESU® Mannitol 200SD, crystalline DESU® Mannitol 160C and a mannitol sample without secondary granulation.
What Is Secondary Granulation?
Secondary granulation is a particle-processing technique in which previously formed granules undergo further processing, such as restructuring, agglomeration, coating or particle shaping, to modify their physical properties.
For pharmaceutical excipients such as mannitol, changes in particle structure may influence interparticle interactions, powder flowability and compression behavior. The effects depend on the starting material, processing method and resulting particle characteristics.
Spray-dried and crystalline mannitol have different particle structures and may respond differently to further particle processing. Therefore, the suitability of a mannitol grade should be assessed using relevant powder characterization and tablet compression tests rather than processing type alone.
Results and Discussion
How Does Mannitol Powder Flowability Differ Among Grades?
Powder-flow properties are important when evaluating pharmaceutical excipients for powder handling, die filling and tablet manufacturing. The reported comparison included the angle of repose, bulk density and Hausner ratio of different mannitol samples.
| Parameter | DESU® Mannitol 200SD | DESU® Mannitol 160C | Mannitol Without Secondary Granulation |
|---|---|---|---|
| Angle of repose | 39° | 50° | 48° |
| Bulk density | 0.4746 g/mL | Not reported | Not reported |
| Hausner ratio | 1.21 | 1.43 | 1.29 |
Note: Values are reproduced from the source material. Unreported values are not inferred.
Among the three samples, DESU® Mannitol 200SD had the lowest angle of repose and Hausner ratio. These results indicate more favorable powder-flow characteristics under the reported test conditions.
Powder-flow indicators should be interpreted together with other material properties and application-specific tests. Actual performance during manufacturing may vary with formulation composition, equipment and processing conditions.
How Does Mannitol Perform in Direct Compression?
Direct compression is a tablet manufacturing process in which blended powders are compressed directly into tablets without a separate granulation step. Selecting an appropriate excipient is important for achieving the required tablet mechanical properties and manufacturing consistency.
According to the reported blank-tablet compression tests, DESU® Mannitol 200SD demonstrated higher tablet hardness and lower friability across the tested compression pressures.
DESU® Mannitol 160C also showed increased tablet hardness at higher compression pressures, with hardness exceeding that of the mannitol sample without secondary granulation.
These findings highlight differences in compression behavior among the tested mannitol samples. Evaluating tablet hardness and friability alongside powder-flow parameters can help formulation developers assess the suitability of a mannitol grade for direct compression.
The reported findings are specific to the tested samples and experimental conditions. Performance in a finished formulation may also depend on the active pharmaceutical ingredient (API), excipient composition, blending process and compression settings.
How to Select Mannitol for Your Formulation
Selecting the right pharmaceutical-grade mannitol requires evaluating several material and process parameters according to the intended formulation and manufacturing method.
- Powder flowability: Assess flow characteristics relevant to powder handling and consistent die filling.
- Compressibility and tabletability: Evaluate the ability of the material to form tablets with the required mechanical properties.
- Tablet hardness and friability: Examine tablet strength and resistance to chipping or abrasion under the intended test conditions.
- Particle structure: Consider particle morphology and interparticle interactions when comparing different mannitol grades.
- Process compatibility: Confirm suitability for the intended manufacturing process, including direct compression where applicable.
No single parameter determines overall excipient performance. Comparative powder characterization and tablet compression studies provide a more complete basis for selecting mannitol for a specific formulation.
Conclusion
Secondary granulation and other particle-engineering approaches can influence the physical properties of mannitol and its behavior during tablet manufacturing. In the reported comparison, DESU® Mannitol 200SD showed favorable powder-flow indicators and strong performance in the tested blank-tablet compression experiments.
For pharmaceutical developers evaluating spray-dried mannitol and other mannitol grades, understanding particle structure, powder flowability, tablet hardness and friability can support informed excipient selection for direct compression and formulation development.
DESU® Mannitol — Supporting Pharmaceutical Formulation Performance.